The Uterine Microbiome: The Unsung Piece of the Fertility Puzzle
Uterine Microbiome · Evidence-Based
Learn More →The Uterine Microbiome: The Unsung Piece of the Fertility Puzzle
The uterus isn’t sterile. Here’s what the research actually shows about how its microbial balance affects implantation and miscarriage risk.
Key Takeaways
- The uterus is not sterile — research over the past decade has confirmed a distinct uterine microbiome, and its balance (specifically Lactobacillus dominance) is linked to implantation success and miscarriage risk.
- Chronic endometritis, a largely symptomless uterine lining inflammation often tied to microbiome imbalance, is found in a meaningful share of women with recurrent implantation failure and recurrent pregnancy loss — though prevalence estimates vary widely across studies (roughly 9-57%, depending on diagnostic criteria).
- In one older but notable study, 55% of women with unexplained infertility tested positive for a bacterial organism called Ureaplasma, and 42% conceived within 6 months of antibiotic treatment alone, without any additional fertility intervention.
- A Lactobacillus-dominant uterine environment isn’t just about avoiding “bad” bacteria — it plays an active, functional role in supporting the immune shift and endometrial changes needed for an embryo to implant and a pregnancy to continue.
- Testing options exist at different levels of investment, from an at-home vaginal microbiome swab to a clinical endometrial biopsy (EMMA/ALICE), and several everyday habits (avoiding vaginal soap and non-fertility-friendly lubricants, moderating sugar and alcohol, and getting enough carbohydrates) can support a healthier baseline microbiome.
Why the Uterine Microbiome Deserves More Attention
For a long time, the uterus was assumed to be a sterile environment, unlike the well-known bacterial ecosystem of the gut. That assumption has changed. Research over roughly the last decade has confirmed that the uterus hosts its own microbiome, and a growing body of evidence suggests that the balance of that microbiome, specifically how Lactobacillus-dominant it is, plays a real role in fertility outcomes.
What Happens When the Uterine Microbiome Is Out of Balance
When the uterine microbiome becomes dysbiotic (an overgrowth of bacteria that either shouldn’t be there in large amounts, or shouldn’t be there at all), research has associated this with increased endometrial inflammation, recurrent implantation failure, and recurrent miscarriage.
One specific condition tied to this is chronic endometritis: a largely asymptomatic inflammation of the uterine lining. Reported prevalence varies significantly across studies depending on diagnostic method, ranging broadly from about 9% to as high as 57% in different infertility, recurrent implantation failure, and recurrent pregnancy loss populations. In one study specifically looking at both RIF and RPL patients using immunohistochemical staining, chronic endometritis was found in 45% of women in both groups. It’s worth being direct about the state of the research here: findings vary a lot between studies, diagnostic criteria aren’t standardized, and some larger recent cohort studies haven’t found a significant link between the number of failed transfers or miscarriages and chronic endometritis prevalence. This remains a genuinely evolving area of research, not a settled one.
Why the Absence of Symptoms Makes This Easy to Miss
Chronic endometritis and uterine dysbiosis are typically silent. There’s usually no pain or obvious warning sign, meaning the only “symptom” is often infertility or pregnancy loss itself. This is a significant part of why it’s easy for this to go unassessed for a long time, particularly since it’s often not investigated until after multiple failed IVF cycles, rather than earlier in a couple’s workup.
The Ureaplasma Studies
A frequently cited (though older) study looked at 200 consecutive infertility patients and 67 fertile controls. Among women with unexplained infertility, 55% tested positive for Ureaplasma urealyticum, compared to 32% of the control group, a statistically significant difference. Following antibiotic treatment, 42% of the unexplained infertility group conceived within 6 months, compared to a historical 32% pregnancy rate in a similar pre-treatment group.
Why Lactobacillus Specifically Matters
A Lactobacillus-dominant environment does more than just crowd out harmful bacteria. It supports a healthy vaginal and uterine pH by producing lactic acid, and it plays a functional role in the biological process of implantation itself — specifically, in supporting the immune system’s shift from a more inflammatory state to the more tolerant state needed to allow an embryo to implant and a pregnancy to continue. Low Lactobacillus levels have also been associated with higher levels of IL-6, a pro-inflammatory marker that has separately been found elevated in women with recurrent pregnancy loss.
It’s also worth understanding that some inflammation is a normal, necessary part of the reproductive cycle and of implantation itself, since Lactobacillus supports proper prostaglandin production. The goal isn’t zero inflammation, it’s balance.
Everyday Factors That Influence Microbiome Health
A few practical, low-cost habits that can support a healthier baseline microbiome:
- Avoid soap or scented washes on the vulva — plain water is sufficient, and added products can disrupt vaginal pH.
- Use fertility-friendly lubricants specifically formulated not to alter vaginal pH, and double-check that any lubricant used doesn’t contain spermicide.
- Moderate sugar intake, since sugar can feed less favorable bacteria.
- Support gut health with adequate fiber, since gut and vaginal/uterine bacteria are connected.
- Be mindful of alcohol consumption, which can disrupt healthy flora.
- Ensure adequate carbohydrate intake. Lactobacillus relies on glycogen (derived from carbohydrates) for fuel, meaning prolonged fasting, very low-carb, or ketogenic/carnivore diets may not support an optimal Lactobacillus environment.
- Be aware of frequent or recent antibiotic use, which can disrupt microbiome balance.
Testing Options
A few ways to investigate uterine and vaginal microbiome health, depending on budget and where you are in your journey:
- Clinical endometrial biopsy (EMMA/ALICE) — the more comprehensive, invasive option typically offered through fertility clinics, though often not until after failed transfers.
- At-home microbiome testing (via companies offering menstrual blood and vaginal swab testing) — a less invasive option that can provide both uterine and vaginal insight, along with treatment guidance based on results.
- A basic vaginal swab (through a provider or at-home kit) — the most accessible starting point, though a clear vaginal result doesn’t guarantee the uterine environment is equally balanced.
Get a Personalized Plan
Wondering If Your Uterine Environment Could Be Part of the Picture?
This is exactly the kind of overlooked factor we dig into with Fertility Confidence Method clients — especially if you’ve been told everything looks “normal” but nothing is working. Book a clarity call and let’s figure out what testing and treatment plan actually makes sense for you.
Book Your Clarity Call →Sources & Further Reading
- Toth, A., et al. On the Etiologic Role of Ureaplasma Urealyticum (T-Mycoplasma) Infection in Infertility. Fertility and Sterility, 1983.
- Recurrent pregnancy loss and the role of Mycoplasma and Ureaplasma: a prospective cohort study with outcome after treatment. Fertility and Sterility, 2025.
- Chronic Endometritis and Uterine Endometrium Microbiota in Recurrent Implantation Failure and Recurrent Pregnancy Loss. PMC, reproductive immunology research.
- Chronic endometritis and recurrent reproductive failure: a systematic review and meta-analysis. PMC, 2024.
- Between evidence and expectation: a retrospective cohort study on chronic endometritis in repeated implantation failure and recurrent pregnancy loss. Reproductive Biology and Endocrinology, 2025.
- The effect of chronic endometritis and treatment on patients with unexplained infertility. PMC.
There’s a 50% Chance Male Fertility Is Keeping You From Getting Pregnant
Half of all infertility cases involve a male factor. Yet sperm testing is still the last thing most couples are told to do — and the numbers being called “normal” are far from it.
- Male factor is involved in 50–70% of infertility cases — yet sperm testing is still routinely the last step, not the first.
- The WHO’s lower limit for “normal” sperm concentration is 15 million/mL — the 5th percentile. At that level, estimated per-cycle pregnancy odds are around 5%.
- Optimal sperm concentration sits at the 50th percentile of men who successfully conceived: approximately 60–73 million/mL.
- Below 30 million/mL, pregnancy probability drops off sharply. Above 50 million/mL it plateaus near the natural per-cycle ceiling of 20–25%.
- Sperm concentration is not fixed. A targeted, data-driven approach can produce significant improvement — often within 3–6 months.
When a couple struggles to conceive, the instinct — in clinical settings and at home — is to start with her. Her cycle, her hormones, her ovulation. This is understandable. It is also costing couples months, and sometimes years, they do not need to lose.
The data is unambiguous: male factor is involved in somewhere between 50 and 70% of infertility cases. Not as a rare secondary concern — as a primary driver, half the time. Yet semen analysis is still treated as the test you run after everything else has been checked, if it gets run at all.
What the statistics actually show
Infertility is clinically defined as 12 consecutive months of trying to conceive without a pregnancy. When researchers break down the causes, the picture looks like this:
This does not change based on prior pregnancies. Sperm quality and concentration shift over time, affected by age, health, stress, illness, and lifestyle. A previous successful conception — in this relationship or a past one — is not a current result. Testing still matters.
Why “normal” doesn’t mean what it sounds like
The reference range most clinics use comes from WHO guidelines. Under those guidelines, a sperm concentration of 15 million per millilitre is considered normal. A man who hits that number is typically told everything looks fine.
What that framing leaves out: 15 million/mL is the 5th percentile. It was derived from a dataset of men who did achieve pregnancy with their partners within 12 months — but the threshold was drawn at the very bottom of that group. Ninety-five percent of those men had better numbers. The threshold was not placed where success is likely. It was placed at the floor of the range where it has occasionally been shown to work.
At 15 million/mL, the estimated per-cycle probability of conception is approximately 5%. That is the number being rubber-stamped as acceptable in clinical semen analysis reporting.
The 50th percentile of that same dataset — the midpoint of men who successfully conceived — sits around 73 million per millilitre. A practical target for optimisation is above 60 million/mL. That gap, between what clears the bar and what actually reflects fertility potential, is not a minor technical distinction. It is where most couples who are told “nothing is wrong” are quietly losing time.
Where the real drop-off happens
Pregnancy probability by sperm concentration is not a linear curve. The steepest decline happens below 30 million/mL — which is still well above the WHO minimum threshold that triggers no clinical concern.
Above 50 million/mL, per-cycle pregnancy probability plateaus near 20–25% — a ceiling that reflects biological limits, not sperm count. Getting from 60 million to 100 million makes little practical difference. Getting from 15 million to 60 million makes a significant one.
Subfertility vs. infertility — and why the gap matters
One reason male factor gets missed is that clinical concern is triggered by infertility thresholds, not subfertility. If a result clears 15 million/mL, it does not prompt a referral or a follow-up conversation. But a man at 25 million/mL is not in the same position as one at 70 million/mL — and treating those results as equivalent is how couples end up in a prolonged stretch of “keep trying” that didn’t need to last as long as it did.
Subfertility — results that are technically within range but far from optimal — is common and, in many cases, improvable. The research base for male fertility nutrition, lifestyle, and supplementation is more robust than most people realise, partly because sperm concentration is a measurable, repeatable endpoint that is straightforward to study. Randomised controlled trials exist. The evidence base is there. But it cannot be applied well without knowing what the actual numbers are.
Getting tested — and reading the results correctly
A clinical semen analysis — where the sample is produced and analysed on-site at a lab — remains the most reliable method. At-home testing has improved; one option used in fertility-focused clinical programmes is Fellow, which runs morphology and returns actual numerical data rather than a simplified pass/fail result. If at-home results come back low or irregular, confirming with a clinical sample before building any treatment plan is the sensible next step.
When results come back, the question is not just whether concentration clears 15 million/mL. It is where concentration sits relative to the 50th-percentile target. Below 60 million/mL, there is room for improvement. Below 30 million/mL, understanding why — structural, hormonal, or lifestyle-related — should come before any intervention is started.
Testing is the beginning of a plan, not the end of a conversation.
The Sperm Count Blueprint
A focused resource for anyone whose sperm concentration is below optimal — or who doesn’t yet know where it stands. Covers how to interpret your numbers, the most common reasons concentration is low, and how to build a targeted plan based on what the research actually supports.
Get the Blueprint → Includes the Full Male Lab GuideReferences
- World Health Organization. (2021). WHO laboratory manual for the examination and processing of human semen (6th ed.). WHO Press. https://www.who.int/publications/i/item/9789240030787 — Source for sperm concentration reference ranges, including the 5th percentile lower threshold of 15 million/mL used in clinical semen analysis reporting.